CD44 receptor targeted ‘smart’ multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer

N. Singhai,R. Maheshwari,S. Ramteke

Published 2020 in Colloid and Interface Science Communications

ABSTRACT

Abstract Triple-negative breast cancer requires high treatment specificity and efficacy due to its aggressive nature. In the present investigation, multi-walled carbon-nanotubes (MWCNTs) were functionalized using Hyaluronic acid (HA) and α-Tocopheryl succinate (α-TOS) and loaded with Doxorubicin (Dox) to obtained novel α-TOS-HA-MWCNTs/Dox conjugate to achieve enhanced cellular-placement and anticancer-therapeutic action against CD44 receptors overexpressing TNBC cells (MDA-MB-231). Interestingly, α-TOS-HA-MWCNTs/Dox displayed high cellular uptake as compared to individually tailored MWCNTs formulations. Anticancer investigation revealed prominent growth inhibition effect (SRB assay; GI50; 0.810 ± 0.017; p

PUBLICATION RECORD

  • Publication year

    2020

  • Venue

    Colloid and Interface Science Communications

  • Publication date

    2020-03-01

  • Fields of study

    Medicine, Materials Science, Chemistry, Engineering

  • Identifiers
  • External record

    Open on Semantic Scholar

  • Source metadata

    Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-39 of 39 references · Page 1 of 1

CITED BY

Showing 1-52 of 52 citing papers · Page 1 of 1